Cargando…

Cyclophosphamide/prednisolone/rituximab: Nosocomial COVID-19 infection: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644413/ http://dx.doi.org/10.1007/s40278-020-84870-z

Ejemplares similares

Cyclophosphamide/rituximab: COVID-19 infection: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone/prednisolone: Multiple infections: case report
Publicado: (2021)

Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report
por: Hojo, Nobumasa, et al.
Publicado: (2022)

Methotrexate/prednisolone/rituximab: COVID-19 pneumonia: 2 case reports
Publicado: (2021)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Prednisolone: COVID-19 infection: case report
Publicado: (2021)

Cyclophosphamide/fludarabine/rituximab: Prolonged viral shedding and protracted COVID-19: case report
Publicado: (2022)

Prednisolone/tacrolimus: COVID-19 infection: case report
Publicado: (2020)

Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020)

Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020)

Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma
por: Hornberger, John, et al.
Publicado: (2008)

Everolimus/prednisolone/tacrolimus: COVID-19 infection: case report
Publicado: (2021)

Mycophenolate-mofetil/prednisolone/rituximab: Treatment-related osteopenia and candidiasis: 7 case reports
Publicado: (2022)

Mycophenolate mofetil/prednisolone/rituximab: SARS-CoV-2 infection and lack of efficacy: 2 case reports
Publicado: (2022)

The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
por: Shimizu, Naomi, et al.
Publicado: (2017)

Prednisolone: COVID-19 pneumonia: case report
Publicado: (2020)

Methotrexate/prednisolone: COVID-19: case report
Publicado: (2021)

Methotrexate/prednisolone: COVID-19: case report
Publicado: (2021)

Gasorelin/prednisolone: COVID-19 infection and weight increase : case report
Publicado: (2020)

Mycophenolate sodium/prednisolone/tacrolimus: COVID-19 infection: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2022)

Mycophenolate mofetil/ciclosporin/prednisolone: COVID-19 infection: 2 case reports
Publicado: (2021)

Ciclosporin/prednisolone: COVID-19 infection and Klebsiella pneumoniae septicaemia: case report
Publicado: (2022)

Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
por: Shin, Junghoon, et al.
Publicado: (2017)

Aortic Aneurysm as a Complication of Granulomatosis with Polyangiitis Successfully Treated with Prednisolone and Cyclophosphamide: A Case Report and Review of the Literature
por: Niimi, Naoko, et al.
Publicado: (2018)

Rituximab: COVID-19 infection: 2 case reports
Publicado: (2020)

Rituximab: COVID-19 infection: 3 case reports
Publicado: (2021)

Rituximab: COVID-19 infection: 8 case reports
Publicado: (2021)

Rituximab: COVID-19 infection: 2 case reports
Publicado: (2022)

Rituximab: Persistent COVID-19 infection: case report
Publicado: (2022)

Methylprednisolone/prednisolone: Masking of COVID-19 infection followed by its reactivation: case report
Publicado: (2021)

Mycophenolate-mofetil/prednisolone/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2022)

Prednisolone/tozinameran: Acquired haemophilia and COVID-19 pneumoniae: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2022)

Ocrelizumab/rituximab: COVID-19 infection: 2 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8754t20l02qrukjiqblfvdu5h